ICICI Prudential Nifty Pharma Index Fund Direct Growth

Fund Overview

Fund Size

₹79 Cr

Expense Ratio

0.35%

ISIN

INF109KC11M9

Minimum SIP

₹1,000

Exit Load

No Charges

Inception Date

15 Dec 2022

About this fund

ICICI Prudential Nifty Pharma Index Fund Direct Growth is a Index Funds mutual fund schemes offered by ICICI Prudential Mutual Fund. This fund has been in existence for 1 years, 11 months and 7 days, having been launched on 15-Dec-22.
As of 21-Nov-24, it has a Net Asset Value (NAV) of ₹16.75, Assets Under Management (AUM) of 78.96 Crores, and an expense ratio of 0.35%.

ICICI Prudential Nifty Pharma Index Fund Direct Growth has given a CAGR return of 30.92% since inception.
The fund's asset allocation comprises around 100.36% in equities, 0.00% in debts, and -0.36% in cash & cash equivalents.
You can start investing in ICICI Prudential Nifty Pharma Index Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹1000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+35.80%

— (Cat Avg.)

Since Inception

+30.92%

— (Cat Avg.)

Portfolio Summaryas of 31st October 2024

Equity	₹79.25 Cr	100.36%
Others	₹-0.28 Cr	-0.36%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹19.88 Cr	25.18%
Cipla Ltd	Equity	₹8.5 Cr	10.76%
Dr Reddy's Laboratories Ltd	Equity	₹7.74 Cr	9.80%
Divi's Laboratories Ltd	Equity	₹7.45 Cr	9.43%
Lupin Ltd	Equity	₹5.25 Cr	6.65%
Aurobindo Pharma Ltd	Equity	₹3.89 Cr	4.92%
Alkem Laboratories Ltd	Equity	₹3.01 Cr	3.81%
Torrent Pharmaceuticals Ltd	Equity	₹2.94 Cr	3.73%
Glenmark Pharmaceuticals Ltd	Equity	₹2.54 Cr	3.22%
Mankind Pharma Ltd	Equity	₹2.51 Cr	3.17%
Zydus Lifesciences Ltd	Equity	₹2.49 Cr	3.16%
Ipca Laboratories Ltd	Equity	₹2.15 Cr	2.72%
Laurus Labs Ltd	Equity	₹1.92 Cr	2.44%
Abbott India Ltd	Equity	₹1.5 Cr	1.90%
Biocon Ltd	Equity	₹1.42 Cr	1.79%
J.B. Chemicals & Pharmaceuticals Ltd	Equity	₹1.39 Cr	1.76%
Gland Pharma Ltd	Equity	₹1.31 Cr	1.65%
Ajanta Pharma Ltd	Equity	₹1.28 Cr	1.63%
Natco Pharma Ltd	Equity	₹1.26 Cr	1.60%
Net Current Assets	Cash	₹-1.18 Cr	1.50%
Treps	Cash - Repurchase Agreement	₹0.9 Cr	1.14%
Granules India Ltd	Equity	₹0.82 Cr	1.04%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹79.25 Cr	100.36%

Risk & Performance Ratios

Fund Managers

Nishit Patel

Since December 2022

Priya Sridhar

Since February 2024

Additional Scheme Detailsas of 31st October 2024

ISIN

INF109KC11M9

Expense Ratio

0.35%

Exit Load

No Charges

Fund Size

₹79 Cr

Age

1 year 11 months

Lumpsum Minimum

₹1,000

Fund Status

Open Ended Investment Company

Benchmark

Nifty Pharma TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Index Funds Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
ICICI Prudential Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹565.80 Cr	29.4%
ICICI Prudential Nifty Midcap 150 Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹565.80 Cr	28.7%
ICICI Prudential Nifty 200 Momentum 30 Index Fund Regular Growth Very High Risk	1.0%	0.0%	₹471.41 Cr	33.6%
SBI Nifty Midcap 150 Index Fund Regular Growth Very High Risk	1.0%	0.0%	₹670.31 Cr	28.8%
DSP Nifty 50 Equal Weight Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹1886.93 Cr	20.2%
SBI Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹1190.98 Cr	28.6%
SBI Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹670.31 Cr	29.5%
ICICI Prudential Nifty 200 Momentum 30 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹471.41 Cr	34.3%
DSP Nifty 50 Equal Weight Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹1886.93 Cr	20.9%
SBI Nifty Smallcap 250 Index Fund Regular Growth Very High Risk	1.0%	0.0%	₹1190.98 Cr	27.8%

About the AMC

ICICI Prudential Mutual Fund

+91 22 26428000

https://www.icicipruamc.com/

Total AUM

₹8,99,267 Cr

Address

3rd Floor, Hallmark Business Plaza, Mumbai, 400 051

Other Funds by ICICI Prudential Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
ICICI Prudential Nifty50 Value 20 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹79.20 Cr	-
ICICI Prudential Fixed Maturity Plan Series 88 182 Days Plan J Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 125 Days Plan H Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 93 Days Plan P Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1199 Days Plan Q Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1858 Days Plan D Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1226 Days Plan F Direct Growth Low to Moderate Risk	-	-	-	8.2%
ICICI Prudential Long Term Wealth Enhancement Fund Direct Growth Very High Risk	1.0%	0.0%	₹42.36 Cr	33.9%
ICICI Prudential Fixed Maturity Plan Series 88 1828 Days Plan A Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1833 Days Plan C Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1192 Days Plan R Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 95 Days Plan B Direct Growth Moderately High risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1303 Days Plan S Direct Growth Low to Moderate Risk	-	0.0%	-	8.6%
ICICI Prudential Fixed Maturity Plan Series 88 226 Days Plan E Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Thematic Advantage Fund (FOF) Direct Growth Very High Risk	1.3%	1.0%	₹1989.95 Cr	31.0%
ICICI Prudential Floating Interest Fund Direct Growth Moderate Risk	0.6%	0.0%	₹8674.64 Cr	9.0%
ICICI Prudential Gilt Fund Direct Growth Moderate Risk	0.6%	0.0%	₹6692.38 Cr	8.8%
ICICI Prudential All Seasons Bond Fund Direct Growth Moderate Risk	0.6%	0.0%	₹13133.03 Cr	9.1%
ICICI Prudential Long Term Bond Fund Direct Growth Moderate Risk	0.4%	0.0%	₹1017.95 Cr	11.0%
ICICI Prudential Liquid Fund Direct Growth Moderate Risk	0.2%	0.0%	₹51423.19 Cr	7.5%
ICICI Prudential Innovation Fund Direct Growth Very High Risk	0.7%	1.0%	₹6322.82 Cr	41.2%
ICICI Prudential Global Stable Equity Fund (FOF) Direct Growth Very High Risk	1.7%	1.0%	₹118.57 Cr	12.1%
ICICI Prudential Bond Fund Direct Growth Moderate Risk	0.6%	0.0%	₹2952.49 Cr	9.3%
ICICI Prudential Smallcap Fund Direct Growth Very High Risk	0.8%	1.0%	₹8435.41 Cr	21.7%
ICICI Prudential Midcap Fund Direct Growth Very High Risk	1.1%	1.0%	₹6330.47 Cr	37.0%
ICICI Prudential Infrastructure Fund Direct Growth Very High Risk	1.2%	1.0%	₹6779.16 Cr	39.9%
ICICI Prudential Nifty 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹11563.15 Cr	19.0%
ICICI Prudential Regular Savings Fund Direct Growth High Risk	0.9%	1.0%	₹3220.38 Cr	13.7%
ICICI Prudential Money Market Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹27974.29 Cr	7.8%
ICICI Prudential Nifty Next 50 Index Direct Growth Very High Risk	0.3%	0.0%	₹6759.07 Cr	43.1%
ICICI Prudential Regular Gold Savings (FOF) Direct Growth High Risk	0.6%	1.0%	₹1325.21 Cr	24.4%
ICICI Prudential Credit Risk Fund Direct Growth High Risk	0.8%	1.0%	₹6387.09 Cr	9.3%
ICICI Prudential Large & Mid Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹17120.29 Cr	31.3%
ICICI Pru Multicap Fund Direct Growth Very High Risk	0.9%	1.0%	₹14152.04 Cr	32.1%
ICICI Prudential Short Term Fund Direct Growth Moderate Risk	0.5%	0.0%	₹19922.45 Cr	8.6%
ICICI Prudential US Bluechip Equity Fund Direct Growth Very High Risk	1.2%	1.0%	₹3221.37 Cr	22.5%
ICICI Prudential Corporate Bond Fund Direct Growth Moderate Risk	0.3%	0.0%	₹27164.45 Cr	8.4%
ICICI Prudential Exports and Services Fund Direct Growth Very High Risk	1.7%	1.0%	₹1482.57 Cr	34.2%
ICICI Prudential Long Term Equity Fund ( Tax Saving) Direct Growth Very High Risk	1.1%	0.0%	₹14346.87 Cr	25.0%
ICICI Prudential Technology Direct Growth Very High Risk	1.0%	1.0%	₹13495.32 Cr	32.7%
ICICI Prudential Income Optimizer Fund (FOF) Direct Growth Moderate Risk	1.1%	1.0%	₹271.33 Cr	14.8%
ICICI Prudential Flexicap Fund Direct Growth Very High Risk	0.8%	1.0%	₹16767.51 Cr	30.0%
ICICI Prudential Equity Savings Fund Direct Growth Moderate Risk	0.5%	0.0%	₹12406.21 Cr	9.9%
ICICI Prudential Retirement Fund Hybrid Aggressive Plan Direct Growth Very High Risk	0.8%	0.0%	₹690.95 Cr	32.9%
ICICI Prudential Retirement Fund Pure Equity Plan Direct Growth Very High Risk	0.7%	0.0%	₹1017.25 Cr	37.6%
ICICI Prudential Retirement Fund Hybrid Conservative Plan Direct Growth Moderately High risk	1.0%	0.0%	₹77.15 Cr	14.1%
ICICI Prudential Retirement Fund Pure Debt Plan Direct Growth Moderate Risk	1.2%	0.0%	₹115.93 Cr	8.5%
ICICI Prudential India Opportunities Fund Direct Growth Very High Risk	0.6%	1.0%	₹24143.14 Cr	31.5%
ICICI Prudential Passive Multi-Asset Fund of Funds Direct Growth High Risk	0.5%	1.0%	₹1118.91 Cr	16.9%
ICICI Prudential Banking and PSU Debt Fund Direct Growth Moderate Risk	0.4%	0.0%	₹9046.67 Cr	8.2%

Risk Level

Your principal amount will be at Very High Risk

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

What is the current NAV of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The NAV of ICICI Prudential Nifty Pharma Index Fund Direct Growth, as of 21-Nov-2024, is ₹16.75.

What is the portfolio composition of ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The fund's allocation of assets is distributed as 100.36% in equities, 0.00% in bonds, and -0.36% in cash and cash equivalents.

Who manages the ICICI Prudential Nifty Pharma Index Fund Direct Growth?

The fund managers responsible for ICICI Prudential Nifty Pharma Index Fund Direct Growth are:-

Nishit Patel
Priya Sridhar

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

Our weekly expert newsletter on stories that matter to your money.

Knowledge Repository

Bonds

IPA

Mutual Funds

Portfolio Management Services

About

Investment Philosophy

Legal

Returns & Cancellation

Security

Terms & Disclosure

KYC Check

©2021-2024 Dezerv. All Rights Reserved

Dezerv Investments Private Limited is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

ICICI Prudential Nifty Pharma Index Fund Direct Growth

Fund Overview